Cite
HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk.
MLA
Aguado-Sierra, Jazmin, et al. “HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk.” Methods in Molecular Biology (Clifton, N.J.), vol. 2716, 2024, pp. 307–34. EBSCOhost, https://doi.org/10.1007/978-1-0716-3449-3_14.
APA
Aguado-Sierra, J., Brigham, R., Baron, A. K., Gomez, P. D., Houzeaux, G., Guerra, J. M., Carreras, F., Filgueiras-Rama, D., Vazquez, M., Iaizzo, P. A., Iles, T. L., & Butakoff, C. (2024). HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk. Methods in Molecular Biology (Clifton, N.J.), 2716, 307–334. https://doi.org/10.1007/978-1-0716-3449-3_14
Chicago
Aguado-Sierra, Jazmin, Renee Brigham, Apollo K Baron, Paula Dominguez Gomez, Guillaume Houzeaux, Jose M Guerra, Francesc Carreras, et al. 2024. “HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk.” Methods in Molecular Biology (Clifton, N.J.) 2716: 307–34. doi:10.1007/978-1-0716-3449-3_14.